Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 3/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | NADK | O95544 | 2/20 | 0.58 |
| ▸ | LDHA | P00338 | 1/20 | 0.56 |
| ▸ | LDHB | P07195 | 1/20 | 0.56 |
| ▸ | P2RY1 | P47900 | 3/20 | 0.55 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.55 |
| ▸ | SRC | P12931 | 1/20 | 0.55 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.55 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.55 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.55 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | IMPDH2 | P12268 | 3/20 | 0.55 |
| ▸ | IMPDH1 | P20839 | 3/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenine SCHEMBL851383 | 0.99 | ADH1A (0.74) | ADH1ALMNAPMP22TP53TSHR | |
| Adenine SCHEMBL23041044 | 0.99 | ADH1A (0.74) | ADH1ALMNAPMP22TP53TSHR | |
| Niacinamide SCHEMBL14861027 | 0.95 | ADH1A (0.84) | ADH1ALMNAPMP22TP53TSHR | |
| Adenine SCHEMBL30498936 | 0.93 | ADH1A (0.73) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL4595394 | 0.91 | ADH1A (0.81) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL8505460 | 0.91 | ADH1A (0.81) | ADH1ALMNAPMP22TP53TSHR | |
| Nicotine SCHEMBL16345 | 0.90 | ADH1A (0.68) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL29350404 | 0.87 | ADH1A (1.00) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL1276381 | 0.87 | ADH1A (1.00) | ADH1ALMNAPMP22TP53TSHR | |
| SCHEMBL8187 | 0.87 | ADH1A (1.00) | ADH1ALMNAPMP22TP53TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 275 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113939598-A | Method, electrochemical sensor and system for selective detection of infection | 德加泰罗尼亚理工大学 | 2022-01-14 | — | — | CN | claimed |
| EP-4626868-A1 | 3-PHENYLQUINAZOLINONES AS NOVEL ANTI-CANCER THERAPY | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) | 2025-10-08 | — | — | EP | disclosed |
| US-20250147048-A1 | METHODS OF DIAGNOSTIC SCREENING AND EARLY DETECTION OF ADENOMYOSIS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2025-05-08 | — | — | US | disclosed |
| US-12188073-B2 | Yeast cells and methods for producing fatty alcohols | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-07 | — | — | US | disclosed |
| WO-2024216115-A1 | METHODS FOR PRODUCING A SUPER CENTRAL MEMORY CD8 T CELL SUBTYPE BY POLY(ADP-RIBOSE) POLYMERASE (PARP) INHIBITION AND USES THEREOF | GEORGETOWN UNIVERSITY (US) | 2024-10-17 | — | — | WO | disclosed |
| US-20240271118-A1 | POLYMERIC ENCAPSULATION OF WHOLE CELLS AS BIOREACTORS | US DEPARTMENT OF ENERGY | 2024-08-15 | — | — | US | disclosed |
| US-12053462-B2 | Quinoline derivatives | GILEAD SCIENCES, INC. (US) | 2024-08-06 | — | — | US | disclosed |
| WO-2024115673-A1 | 3-PHENYLQUINAZOLINONES AS NOVEL ANTI-CANCER THERAPY | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024015934-A2 | METHODS OF DIAGNOSTIC SCREENING AND EARLY DETECTION OF ADENOMYOSIS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2024-01-18 | — | — | WO | disclosed |
| CN-110951720-B | Immobilized proteins and uses thereof | 恩制因塞米公司 | 2023-08-18 | — | — | CN | disclosed |
| US-4927752-A | Support used in bioluminescent dosing of enzymes, substrates or enzymatic inhibitors | REMACLE, JOSE (BE) | 1990-05-22 | — | — | US | disclosed |
| EP-0229085-A1 | SUPPORT USED IN BIOLUMINESCENT DOSING OF ENZYMES, SUBSTRATES OR ENZYMATIC INHIBITORS. | BIOTEC SA (BE) | 1987-07-22 | — | — | EP | disclosed |
| WO-1987000198-A1 | SUPPORT USED IN BIOLUMINESCENT DOSING OF ENZYMES, SUBSTRATES OR ENZYMATIC INHIBITORS | BIOTEC S.A. (BE) | 1987-01-15 | — | — | WO | disclosed |
| US-4394445-A | LYPASE MIXTURE | COOPERBIOMEDICAL, INC., 3145 PORTER DRIVE, PALO ALTO CA. 94304 A CORP OF DE | 1983-07-19 | — | — | US | disclosed |
| EP-0072581-A1 | The stabilization of working reagent solutions containing enzymes, and the use of such stabilized reagents in enzyme or substrate assays | American Monitor Corporation (US) | 1983-02-23 | — | — | EP | disclosed |
| US-4371611-A | BINDING HEXOKINASE OR GLUCOSE 6-PHOSPHATE DEHYDROGENASE TO AN AMINO ACID- CARBODIIMIDE-MODIFIED POLYETHERURETHANE; IMMABILIZATION | W. R. GRACE & CO. (US) | 1983-02-01 | — | — | US | disclosed |
| US-4245041-A | Triglycerides assay and reagents therefor | AMERICAN MONITOR CORPORATION (US) | 1981-01-13 | — | — | US | disclosed |
| US-4233402-A | CHEMICAL ANALYSIS OF A BINDING PAIR OF LIGANDS AND ENZYMES BY LIGHT SIGNALS | SYVA COMPANY (US) | 1980-11-11 | — | — | US | disclosed |
| US-4226935-A | HEXOKINASE AND GLUCOSE-6-PHOSPHATE DEHYDROGENASE BOUND TO CARBOXYLATED POLYETHERURETHANE COPOLYMER | W. R. GRACE & CO. (US) | 1980-10-07 | — | — | US | disclosed |
| EP-0009222-A2 | The stabilization of working reagent solutions containing NADH, NADPH, and/or enzymes, and the use of such stabilized reagents in enzyme or substrate assays | American Monitor Corp. (US) | 1980-04-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12053462-B2 | Quinoline derivatives | CFTR, NQO1, IRF3 | ADH1A 1214/4885LMNA 2900/4885PMP22 1763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.